059: Identification of novel subtype-specific alterations as candidates for drug targets and characterization of intratumour genetic heterogeneity and its contribution to therapy resistance in high-grade serous ovarian cancer (HGSOC)

HIPO Investigator:

PD Dr. Frederik Marmé

Dr. Marc Zapatka

Prof. Dr. Peter Lichter

Dr. Martin Sprick

Prof. Dr. Andreas Trumpp

Prof. Peter Sinn

Dr. Monika Hämmerle

Prof. Dr. Barbara Burwinkel

Prof. Dr. Andreas Schneeweiss

Prof. Dr. Benedikt Brors

 

Entity: HGSOC

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok Decline